Gainers

  • SSLJ.com Limited SSLJ shares surged 86 percent to $0.95.
  • Achieve Life Sciences, Inc. ACHV shares jumped 54.6 percent to $4.2201 after reporting results from study evaluating effect of food on bioavailability of new formulation of cytisine.
  • Arvinas Holding Company, LLC ARVN shares rose 24 percent to $19.845. Arvinas priced its IPO Priced at $16 per share.
  • New Concept Energy, Inc. GBR gained 20.8 percent to $2.61 after declining 8.91 percent on Wednesday.
  • Cameco Corporation CCJ shares climbed 16.3 percent to $11.435 after receiving favorable Tax Court of Canada ruling.
  • Protagonist Therapeutics Inc PTGX gained 14.4 percent to $10.16 after the company reported Fast Track designation for PTG-300.
  • India Globalization Capital, Inc. IGC gained 14.4 percent to $3.4550 after climbing 29.61 percent on Wednesday.
  • Restoration Robotics, Inc. HAIR shares rose 11.2 percent to $2.69.
  • Destination Maternity Corporation DEST surged 10.1 percent to $4.70 after reporting a new 5-year $76 million re-financing with BofA.
  • GW Pharmaceuticals plc GWPH shares rose 9.1 percent to $177.98 after the DEA rescheduled the company's EPIDIOLEX (Cannabidiol) oral solution to schedule V, the lowest restriction classification by the DEA.
  • Liquidia Technologies, Inc. LQDA gained 8.3 percent to $27.2027.
  • DHI Group, Inc. DHX gained 7.5 percent to $2.15. DHI Group named Christian Dwyer as its new Chief Product Officer.
  • Laix Inc. LAIX rose 7.3 percent to $13.42. LAIX priced its IPO at $12.50 per ADS.
  • Applied Genetic Technologies Corporation AGTC shares rose 7 percent to $6.95 after gaining 3.17 percent on Wednesday.
  • Aircastle Limited AYR rose 6.5 percent to $22.25. Cowen & Co. upgraded Aircastle from Market Perform to Outperform.
  • CyberArk Software Ltd. CYBR gained 6.3 percent to $78.09. Morgan Stanley upgraded Cyberark from Equal-Weight to Overweight.
  • Alaska Air Group, Inc. ALK rose 4.1 percent to $69.82. Imperial Capital upgraded Alaska Air from In-Line to Outperform.

 

Check out these big penny stock gainers and losers

Losers

  • Geron Corporation GERN shares dipped 63.9 percent to $2.25 after the company reported discontinuation of imetelstat collaboration with Janssen.
  • Bed Bath & Beyond Inc. BBBY dropped 22.5 percent to $14.57 after the company reported weaker-than-expected results for its second quarter. The company sees FY18 EPS at the low end of its previously guided range. Second-quarter comps were down 0.6 percent.
  • Urovant Sciences Ltd. UROV dropped 20 percent to $11.19. Urovant Sciences priced its IPO at $14 per share.
  • Veru Inc VERU fell 19.4 percent to $1.37 after reporting a common stock offering.
  • Oasmia Pharmaceutical AB OASM fell 16.3 percent to $4.48 after climbing 15.05 percent on Wednesday.
  • Altimmune, Inc. ALT shares dropped 16.3 percent to $10.15.
  • ChemoCentryx Inc CCXI fell 16 percent to $11.08 after the company reported a $75 million common stock offering.
  • Cellectar Biosciences, Inc. CLRB dipped 12.9 percent to $2.92.
  • Applied Optoelectronics, Inc. AAOI fell 12.6 percent to $27.40. Loop Capital downgraded Applied Optoelectronics from Hold to Sell and lowered the price target from $45 to $20.
  • Comtech Telecomm. Corp. CMTL shares fell 12.3 percent to $32.01. Comtech Telecomm reported better-than-expected earnings for its fourth quarter, while sales missed estimates.
  • Level Brands, Inc. LEVB dropped 11.5 percent to $3.54.
  • CDTi Advanced Materials, Inc. CDTI fell 11.1 percent to $2.4899 after surging 47.37 percent on Wednesday.
  • Verastem, Inc. VSTM dipped 8.7 percent to $6.73.
  • Coeur Mining, Inc. CDE shares dropped 8.4 percent to $5.13.
  • SAExploration Holdings, Inc. SAEX dipped 7.8 percent to $11.2463.
  • Carnival Corporation CCL shares fell 6.8 percent to $62.41 after the company reported mixed Q3 earnings end issued Q4 and FY18 guidance below estimates.
  • Kimbell Royalty Partners, LP KRP shares fell 6.7 percent to $19.59 after reporting public offering of common units.
  • Cantel Medical Corp CMD dipped 6.5 percent to $90.55 following Q4 earnings.
  • Conagra Brands Inc CAG fell 5.7 percent to $34.02 after the company posted downbeat results for its first quarter and issued weak forecast for the current quarter.
Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!